Location History:
- Sunny Isles, FL (US) (2014)
- Surrey, GB (2011 - 2016)
- London, GB (2014 - 2019)
Company Filing History:
Years Active: 2011-2019
Title: **The Innovative Journey of Xian-Ming Zeng: Pioneering Advances in Inhalation Technology**
Introduction
Xian-Ming Zeng, based in London, GB, stands out as a prominent inventor with a strong portfolio of 9 patents. His focus on enhancing inhalation devices showcases his commitment to advancing medical technology and improving patient health outcomes.
Latest Patents
Among his most recent contributions is a cutting-edge invention: an airflow adaptor for a breath-actuated dry powder inhaler. This innovative adaptor features a conduit with both a proximal and distal end, designed to enable fluid communication from a deagglomerator outlet port. Notably, it incorporates provisions for independent airflow from the proximal end to the distal end. This occurs without interference from the airflow in the conduit, especially when a breath-induced low pressure is applied at the distal end of the adaptor. This development is set to significantly enhance the performance of inhalation devices, offering better usability for patients.
Career Highlights
Xian-Ming Zeng is currently affiliated with Norton Healthcare Limited, where he applies his expertise in medical device innovation. His work has been instrumental in pushing the boundaries of inhalation technology, positioning him as a key player in the industry.
Collaborations
In his career, Zeng has collaborated with talented colleagues, including Julian Alexander Blair and Daniel R Buck. These partnerships have fostered an environment of creativity and knowledge sharing, ultimately benefiting the innovations produced at Norton Healthcare Limited.
Conclusion
Xian-Ming Zeng's contributions to the field of inhalation technology are remarkable, as evidenced by his patents and collaborations. His innovative spirit and focus on improving patient experiences will surely continue to influence the medical device landscape for years to come.